nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—ADORA1—Gabapentin—epilepsy syndrome	0.28	0.406	CbGbCtD
Oxtriphylline—HDAC2—Valproic Acid—epilepsy syndrome	0.242	0.35	CbGbCtD
Oxtriphylline—SLC22A7—Valproic Acid—epilepsy syndrome	0.0603	0.0874	CbGbCtD
Oxtriphylline—CYP1A2—Carbamazepine—epilepsy syndrome	0.0219	0.0317	CbGbCtD
Oxtriphylline—CYP1A2—Primidone—epilepsy syndrome	0.0204	0.0296	CbGbCtD
Oxtriphylline—CYP1A2—Propofol—epilepsy syndrome	0.0183	0.0265	CbGbCtD
Oxtriphylline—CYP1A2—Phenobarbital—epilepsy syndrome	0.0175	0.0253	CbGbCtD
Oxtriphylline—CYP1A2—Diazepam—epilepsy syndrome	0.0166	0.024	CbGbCtD
Oxtriphylline—CYP1A2—Valproic Acid—epilepsy syndrome	0.0131	0.0189	CbGbCtD
Oxtriphylline—Injection site reaction—Amobarbital—epilepsy syndrome	0.00546	0.26	CcSEcCtD
Oxtriphylline—PDE4C—ganglion—epilepsy syndrome	0.00526	0.0568	CbGeAlD
Oxtriphylline—HDAC2—telencephalic ventricle—epilepsy syndrome	0.00524	0.0566	CbGeAlD
Oxtriphylline—PDE4C—tongue—epilepsy syndrome	0.0052	0.0562	CbGeAlD
Oxtriphylline—Injection site reaction—Phenobarbital—epilepsy syndrome	0.0041	0.195	CcSEcCtD
Oxtriphylline—ADORA2A—ganglion—epilepsy syndrome	0.00383	0.0413	CbGeAlD
Oxtriphylline—ADORA1—ganglion—epilepsy syndrome	0.0033	0.0357	CbGeAlD
Oxtriphylline—HDAC2—tongue—epilepsy syndrome	0.00323	0.0349	CbGeAlD
Oxtriphylline—Caffeine—ATM—epilepsy syndrome	0.00314	0.76	CrCbGaD
Oxtriphylline—Injection site reaction—Fosphenytoin—epilepsy syndrome	0.00283	0.135	CcSEcCtD
Oxtriphylline—Injection site reaction—Diazepam—epilepsy syndrome	0.00272	0.129	CcSEcCtD
Oxtriphylline—HDAC2—hindbrain—epilepsy syndrome	0.00247	0.0267	CbGeAlD
Oxtriphylline—Injection site reaction—Phenytoin—epilepsy syndrome	0.00246	0.117	CcSEcCtD
Oxtriphylline—PDE3B—forebrain—epilepsy syndrome	0.00233	0.0251	CbGeAlD
Oxtriphylline—PDE4C—brainstem—epilepsy syndrome	0.00229	0.0247	CbGeAlD
Oxtriphylline—PDE4C—forebrain—epilepsy syndrome	0.00221	0.0238	CbGeAlD
Oxtriphylline—PDE4C—telencephalon—epilepsy syndrome	0.00203	0.0219	CbGeAlD
Oxtriphylline—Injection site reaction—Valproic Acid—epilepsy syndrome	0.00181	0.086	CcSEcCtD
Oxtriphylline—PDE4D—telencephalon—epilepsy syndrome	0.00179	0.0193	CbGeAlD
Oxtriphylline—Injection site reaction—Pregabalin—epilepsy syndrome	0.00163	0.0777	CcSEcCtD
Oxtriphylline—ADORA2A—forebrain—epilepsy syndrome	0.0016	0.0173	CbGeAlD
Oxtriphylline—PDE4A—telencephalon—epilepsy syndrome	0.00158	0.0171	CbGeAlD
Oxtriphylline—ADORA2A—telencephalon—epilepsy syndrome	0.00148	0.0159	CbGeAlD
Oxtriphylline—HDAC2—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.00147	0.57	CbGdCrCtD
Oxtriphylline—PDE4C—midbrain—epilepsy syndrome	0.00146	0.0157	CbGeAlD
Oxtriphylline—HDAC2—brainstem—epilepsy syndrome	0.00142	0.0153	CbGeAlD
Oxtriphylline—ADORA1—forebrain—epilepsy syndrome	0.00139	0.015	CbGeAlD
Oxtriphylline—HDAC2—forebrain—epilepsy syndrome	0.00137	0.0148	CbGeAlD
Oxtriphylline—ADORA1—telencephalon—epilepsy syndrome	0.00127	0.0138	CbGeAlD
Oxtriphylline—PDE4C—head—epilepsy syndrome	0.00126	0.0136	CbGeAlD
Oxtriphylline—HDAC2—telencephalon—epilepsy syndrome	0.00126	0.0136	CbGeAlD
Oxtriphylline—PDE4C—nervous system—epilepsy syndrome	0.0012	0.0129	CbGeAlD
Oxtriphylline—PDE3B—cerebellum—epilepsy syndrome	0.00119	0.0128	CbGeAlD
Oxtriphylline—PDE4C—central nervous system—epilepsy syndrome	0.00115	0.0125	CbGeAlD
Oxtriphylline—HDAC2—Niclosamide—Clonazepam—epilepsy syndrome	0.00111	0.43	CbGdCrCtD
Oxtriphylline—ADORA2B—head—epilepsy syndrome	0.0011	0.0119	CbGeAlD
Oxtriphylline—ADORA2B—nervous system—epilepsy syndrome	0.00105	0.0113	CbGeAlD
Oxtriphylline—ADORA2A—spinal cord—epilepsy syndrome	0.00103	0.0112	CbGeAlD
Oxtriphylline—PDE4B—forebrain—epilepsy syndrome	0.00102	0.0111	CbGeAlD
Oxtriphylline—ADORA2B—central nervous system—epilepsy syndrome	0.00101	0.0109	CbGeAlD
Oxtriphylline—ADORA1—medulla oblongata—epilepsy syndrome	0.001	0.0108	CbGeAlD
Oxtriphylline—PDE4D—cerebellum—epilepsy syndrome	0.000992	0.0107	CbGeAlD
Oxtriphylline—HDAC2—medulla oblongata—epilepsy syndrome	0.000989	0.0107	CbGeAlD
Oxtriphylline—ADORA2B—cerebellum—epilepsy syndrome	0.000985	0.0106	CbGeAlD
Oxtriphylline—PDE3B—brain—epilepsy syndrome	0.000966	0.0104	CbGeAlD
Oxtriphylline—PDE4B—telencephalon—epilepsy syndrome	0.000943	0.0102	CbGeAlD
Oxtriphylline—ADORA2A—head—epilepsy syndrome	0.000919	0.00993	CbGeAlD
Oxtriphylline—PDE4C—brain—epilepsy syndrome	0.000916	0.00989	CbGeAlD
Oxtriphylline—ADORA1—midbrain—epilepsy syndrome	0.000915	0.00988	CbGeAlD
Oxtriphylline—HDAC2—midbrain—epilepsy syndrome	0.000904	0.00976	CbGeAlD
Oxtriphylline—ADORA1—spinal cord—epilepsy syndrome	0.000893	0.00964	CbGeAlD
Oxtriphylline—PDE4A—cerebellum—epilepsy syndrome	0.000878	0.00949	CbGeAlD
Oxtriphylline—ADORA2A—nervous system—epilepsy syndrome	0.000871	0.00941	CbGeAlD
Oxtriphylline—ADORA2A—central nervous system—epilepsy syndrome	0.000839	0.00906	CbGeAlD
Oxtriphylline—ADORA2A—cerebellum—epilepsy syndrome	0.00082	0.00886	CbGeAlD
Oxtriphylline—PDE4D—brain—epilepsy syndrome	0.000806	0.00871	CbGeAlD
Oxtriphylline—ADORA2B—brain—epilepsy syndrome	0.0008	0.00864	CbGeAlD
Oxtriphylline—ADORA1—head—epilepsy syndrome	0.000793	0.00857	CbGeAlD
Oxtriphylline—HDAC2—head—epilepsy syndrome	0.000784	0.00847	CbGeAlD
Oxtriphylline—ADORA1—nervous system—epilepsy syndrome	0.000752	0.00813	CbGeAlD
Oxtriphylline—HDAC2—nervous system—epilepsy syndrome	0.000743	0.00803	CbGeAlD
Oxtriphylline—PDE4B—medulla oblongata—epilepsy syndrome	0.000741	0.008	CbGeAlD
Oxtriphylline—PDE3A—cerebellum—epilepsy syndrome	0.000726	0.00785	CbGeAlD
Oxtriphylline—ADORA1—central nervous system—epilepsy syndrome	0.000724	0.00782	CbGeAlD
Oxtriphylline—HDAC2—central nervous system—epilepsy syndrome	0.000715	0.00773	CbGeAlD
Oxtriphylline—PDE4A—brain—epilepsy syndrome	0.000713	0.0077	CbGeAlD
Oxtriphylline—ADORA1—cerebellum—epilepsy syndrome	0.000708	0.00765	CbGeAlD
Oxtriphylline—HDAC2—cerebellum—epilepsy syndrome	0.000699	0.00755	CbGeAlD
Oxtriphylline—PDE4B—midbrain—epilepsy syndrome	0.000677	0.00731	CbGeAlD
Oxtriphylline—ADORA2A—brain—epilepsy syndrome	0.000666	0.00719	CbGeAlD
Oxtriphylline—PDE4B—spinal cord—epilepsy syndrome	0.00066	0.00713	CbGeAlD
Oxtriphylline—SLC22A7—brain—epilepsy syndrome	0.00066	0.00713	CbGeAlD
Oxtriphylline—PDE3A—brain—epilepsy syndrome	0.00059	0.00637	CbGeAlD
Oxtriphylline—PDE4B—head—epilepsy syndrome	0.000587	0.00634	CbGeAlD
Oxtriphylline—ADORA1—brain—epilepsy syndrome	0.000575	0.00621	CbGeAlD
Oxtriphylline—HDAC2—brain—epilepsy syndrome	0.000568	0.00613	CbGeAlD
Oxtriphylline—PDE4B—nervous system—epilepsy syndrome	0.000556	0.00601	CbGeAlD
Oxtriphylline—PDE4B—central nervous system—epilepsy syndrome	0.000536	0.00579	CbGeAlD
Oxtriphylline—PDE4B—cerebellum—epilepsy syndrome	0.000524	0.00566	CbGeAlD
Oxtriphylline—PDE4B—brain—epilepsy syndrome	0.000425	0.00459	CbGeAlD
Oxtriphylline—Theophylline—CYP2D6—epilepsy syndrome	0.00037	0.0895	CrCbGaD
Oxtriphylline—Caffeine—CYP2D6—epilepsy syndrome	0.000363	0.0879	CrCbGaD
Oxtriphylline—Caffeine—ABCB1—epilepsy syndrome	0.000259	0.0628	CrCbGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IL6ST—epilepsy syndrome	1.07e-05	5.67e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ADAM10—epilepsy syndrome	1.07e-05	5.66e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—KDR—epilepsy syndrome	1.07e-05	5.64e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCR5—epilepsy syndrome	1.07e-05	5.64e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CCL2—epilepsy syndrome	1.07e-05	5.64e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TSC2—epilepsy syndrome	1.06e-05	5.6e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—AGT—epilepsy syndrome	1.06e-05	5.59e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCR5—epilepsy syndrome	1.05e-05	5.57e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CCL2—epilepsy syndrome	1.05e-05	5.56e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—PRKCB—epilepsy syndrome	1.04e-05	5.52e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—HTR2A—epilepsy syndrome	1.04e-05	5.52e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—AVP—epilepsy syndrome	1.04e-05	5.51e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IL6ST—epilepsy syndrome	1.04e-05	5.5e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—APOE—epilepsy syndrome	1.04e-05	5.48e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—HTR2A—epilepsy syndrome	1.03e-05	5.45e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TSC2—epilepsy syndrome	1.03e-05	5.45e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—AGT—epilepsy syndrome	1.03e-05	5.44e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—PRKCB—epilepsy syndrome	1.03e-05	5.43e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—AKT1—epilepsy syndrome	1.02e-05	5.41e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IL6ST—epilepsy syndrome	1.02e-05	5.41e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ATIC—epilepsy syndrome	1.02e-05	5.4e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—UPB1—epilepsy syndrome	1.02e-05	5.4e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NEU1—epilepsy syndrome	1.02e-05	5.4e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—KDR—epilepsy syndrome	1.02e-05	5.37e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—S100B—epilepsy syndrome	1.01e-05	5.35e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—APOE—epilepsy syndrome	1.01e-05	5.33e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SOCS3—epilepsy syndrome	1e-05	5.3e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CDC42—epilepsy syndrome	1e-05	5.29e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TSC2—epilepsy syndrome	9.92e-06	5.24e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—AGT—epilepsy syndrome	9.91e-06	5.24e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—KDR—epilepsy syndrome	9.88e-06	5.22e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—HES1—epilepsy syndrome	9.86e-06	5.21e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	9.84e-06	5.2e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—POMC—epilepsy syndrome	9.81e-06	5.18e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TSC2—epilepsy syndrome	9.81e-06	5.18e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—AGT—epilepsy syndrome	9.79e-06	5.17e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PRKCB—epilepsy syndrome	9.78e-06	5.17e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IL6ST—epilepsy syndrome	9.74e-06	5.15e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—APOE—epilepsy syndrome	9.71e-06	5.13e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—AVP—epilepsy syndrome	9.69e-06	5.12e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CCL2—epilepsy syndrome	9.6e-06	5.07e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—APOE—epilepsy syndrome	9.6e-06	5.07e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—FYN—epilepsy syndrome	9.59e-06	5.06e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—H2AFX—epilepsy syndrome	9.55e-06	5.05e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MEF2C—epilepsy syndrome	9.54e-06	5.04e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—POMC—epilepsy syndrome	9.52e-06	5.03e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PRKCB—epilepsy syndrome	9.51e-06	5.03e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—KDR—epilepsy syndrome	9.51e-06	5.03e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—FGF2—epilepsy syndrome	9.51e-06	5.02e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GBE1—epilepsy syndrome	9.5e-06	5.02e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	9.5e-06	5.02e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IL6ST—epilepsy syndrome	9.48e-06	5.01e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—KDR—epilepsy syndrome	9.4e-06	4.97e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—POMC—epilepsy syndrome	9.36e-06	4.94e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CCL2—epilepsy syndrome	9.31e-06	4.92e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	9.29e-06	4.91e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—YWHAZ—epilepsy syndrome	9.22e-06	4.87e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—HES1—epilepsy syndrome	9.17e-06	4.84e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CCL2—epilepsy syndrome	9.16e-06	4.84e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PRKCB—epilepsy syndrome	9.16e-06	4.84e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IL6ST—epilepsy syndrome	9.12e-06	4.82e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NGF—epilepsy syndrome	9.11e-06	4.81e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PRKCB—epilepsy syndrome	9.05e-06	4.78e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IL6ST—epilepsy syndrome	9.01e-06	4.76e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	8.94e-06	4.72e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—FYN—epilepsy syndrome	8.91e-06	4.71e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—POMC—epilepsy syndrome	8.91e-06	4.71e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—H2AFX—epilepsy syndrome	8.88e-06	4.69e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCR5—epilepsy syndrome	8.86e-06	4.68e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MEF2C—epilepsy syndrome	8.86e-06	4.68e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—RELA—epilepsy syndrome	8.83e-06	4.66e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—FGF2—epilepsy syndrome	8.75e-06	4.62e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CCL2—epilepsy syndrome	8.72e-06	4.61e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	8.69e-06	4.59e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—FGF2—epilepsy syndrome	8.68e-06	4.58e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—HTR2A—epilepsy syndrome	8.68e-06	4.58e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—POMC—epilepsy syndrome	8.67e-06	4.58e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MTOR—epilepsy syndrome	8.66e-06	4.57e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	8.57e-06	4.53e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCL2—epilepsy syndrome	8.48e-06	4.48e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NGF—epilepsy syndrome	8.47e-06	4.48e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALAD—epilepsy syndrome	8.47e-06	4.48e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NT5E—epilepsy syndrome	8.47e-06	4.48e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—FGF2—epilepsy syndrome	8.41e-06	4.45e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—POMC—epilepsy syndrome	8.34e-06	4.41e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—FGF2—epilepsy syndrome	8.28e-06	4.37e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—POMC—epilepsy syndrome	8.24e-06	4.36e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCR5—epilepsy syndrome	8.24e-06	4.35e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TSC2—epilepsy syndrome	8.24e-06	4.35e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—AGT—epilepsy syndrome	8.23e-06	4.35e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—AKT1—epilepsy syndrome	8.19e-06	4.33e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCL2—epilepsy syndrome	8.16e-06	4.31e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	8.08e-06	4.27e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	8.08e-06	4.27e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCL2—epilepsy syndrome	8.07e-06	4.26e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—APOE—epilepsy syndrome	8.07e-06	4.26e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—HTR2A—epilepsy syndrome	8.07e-06	4.26e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—RELA—epilepsy syndrome	8.05e-06	4.25e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—AKT1—epilepsy syndrome	8.03e-06	4.24e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—MTOR—epilepsy syndrome	7.96e-06	4.21e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CASP3—epilepsy syndrome	7.96e-06	4.21e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	7.91e-06	4.18e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—KDR—epilepsy syndrome	7.9e-06	4.17e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MTOR—epilepsy syndrome	7.9e-06	4.17e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PTGS2—epilepsy syndrome	7.89e-06	4.17e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—FGF2—epilepsy syndrome	7.88e-06	4.16e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—RELA—epilepsy syndrome	7.81e-06	4.13e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ADSL—epilepsy syndrome	7.75e-06	4.09e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—JUN—epilepsy syndrome	7.73e-06	4.09e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—RELA—epilepsy syndrome	7.68e-06	4.06e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—FGF2—epilepsy syndrome	7.66e-06	4.05e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TSC2—epilepsy syndrome	7.66e-06	4.05e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MTOR—epilepsy syndrome	7.66e-06	4.05e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—AGT—epilepsy syndrome	7.65e-06	4.04e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PRKCB—epilepsy syndrome	7.61e-06	4.02e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GLUL—epilepsy syndrome	7.6e-06	4.01e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IL6ST—epilepsy syndrome	7.58e-06	4e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MTOR—epilepsy syndrome	7.53e-06	3.98e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MMP9—epilepsy syndrome	7.52e-06	3.97e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—APOE—epilepsy syndrome	7.5e-06	3.96e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	7.46e-06	3.94e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—FGF2—epilepsy syndrome	7.38e-06	3.9e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—KDR—epilepsy syndrome	7.35e-06	3.88e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	7.33e-06	3.87e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—RELA—epilepsy syndrome	7.31e-06	3.86e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—AKT1—epilepsy syndrome	7.3e-06	3.85e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—FGF2—epilepsy syndrome	7.29e-06	3.85e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CASP3—epilepsy syndrome	7.26e-06	3.84e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MTOR—epilepsy syndrome	7.17e-06	3.79e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—RELA—epilepsy syndrome	7.11e-06	3.76e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—AKT1—epilepsy syndrome	7.11e-06	3.76e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PRKCB—epilepsy syndrome	7.07e-06	3.74e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—JUN—epilepsy syndrome	7.06e-06	3.73e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CASP3—epilepsy syndrome	7.05e-06	3.72e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IL6ST—epilepsy syndrome	7.04e-06	3.72e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—AKT1—epilepsy syndrome	6.99e-06	3.7e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MTOR—epilepsy syndrome	6.98e-06	3.69e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	6.98e-06	3.69e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—SRC—epilepsy syndrome	6.94e-06	3.66e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CASP3—epilepsy syndrome	6.93e-06	3.66e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—POMC—epilepsy syndrome	6.93e-06	3.66e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MMP9—epilepsy syndrome	6.86e-06	3.63e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—RELA—epilepsy syndrome	6.85e-06	3.62e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—JUN—epilepsy syndrome	6.84e-06	3.62e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCL2—epilepsy syndrome	6.78e-06	3.58e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AQP1—epilepsy syndrome	6.77e-06	3.58e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—RELA—epilepsy syndrome	6.77e-06	3.57e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—VEGFA—epilepsy syndrome	6.76e-06	3.57e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—JUN—epilepsy syndrome	6.73e-06	3.56e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MTOR—epilepsy syndrome	6.72e-06	3.55e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—AKT1—epilepsy syndrome	6.66e-06	3.52e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MMP9—epilepsy syndrome	6.66e-06	3.52e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—AKT1—epilepsy syndrome	6.66e-06	3.52e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MTOR—epilepsy syndrome	6.64e-06	3.51e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CASP3—epilepsy syndrome	6.6e-06	3.48e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MMP9—epilepsy syndrome	6.55e-06	3.46e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.5e-06	3.44e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—AKT1—epilepsy syndrome	6.48e-06	3.42e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—AKT1—epilepsy syndrome	6.46e-06	3.41e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—POMC—epilepsy syndrome	6.44e-06	3.4e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CASP3—epilepsy syndrome	6.42e-06	3.39e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—JUN—epilepsy syndrome	6.41e-06	3.38e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—SRC—epilepsy syndrome	6.38e-06	3.37e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—AKT1—epilepsy syndrome	6.35e-06	3.36e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—SRC—epilepsy syndrome	6.33e-06	3.34e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCL2—epilepsy syndrome	6.3e-06	3.33e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.23e-06	3.29e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MMP9—epilepsy syndrome	6.23e-06	3.29e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—JUN—epilepsy syndrome	6.23e-06	3.29e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CASP3—epilepsy syndrome	6.18e-06	3.26e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—VEGFA—epilepsy syndrome	6.16e-06	3.26e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—AKT1—epilepsy syndrome	6.16e-06	3.25e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—SRC—epilepsy syndrome	6.14e-06	3.24e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—FGF2—epilepsy syndrome	6.13e-06	3.24e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	6.12e-06	3.24e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	6.12e-06	3.24e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CASP3—epilepsy syndrome	6.1e-06	3.22e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MMP9—epilepsy syndrome	6.06e-06	3.2e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—AKT1—epilepsy syndrome	6.05e-06	3.19e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—SRC—epilepsy syndrome	6.04e-06	3.19e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—JUN—epilepsy syndrome	6e-06	3.17e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—VEGFA—epilepsy syndrome	5.98e-06	3.16e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—JUN—epilepsy syndrome	5.93e-06	3.13e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—AKT1—epilepsy syndrome	5.88e-06	3.11e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—VEGFA—epilepsy syndrome	5.88e-06	3.11e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MMP9—epilepsy syndrome	5.84e-06	3.08e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MMP9—epilepsy syndrome	5.77e-06	3.05e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—SRC—epilepsy syndrome	5.75e-06	3.04e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.7e-06	3.01e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—FGF2—epilepsy syndrome	5.7e-06	3.01e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—RELA—epilepsy syndrome	5.69e-06	3e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—AKT1—epilepsy syndrome	5.66e-06	2.99e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—VEGFA—epilepsy syndrome	5.6e-06	2.96e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—AKT1—epilepsy syndrome	5.59e-06	2.96e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—SRC—epilepsy syndrome	5.59e-06	2.95e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.59e-06	2.95e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MTOR—epilepsy syndrome	5.58e-06	2.95e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—VEGFA—epilepsy syndrome	5.45e-06	2.88e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—SRC—epilepsy syndrome	5.38e-06	2.84e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—SRC—epilepsy syndrome	5.32e-06	2.81e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—RELA—epilepsy syndrome	5.29e-06	2.79e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—VEGFA—epilepsy syndrome	5.24e-06	2.77e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MTOR—epilepsy syndrome	5.19e-06	2.74e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—VEGFA—epilepsy syndrome	5.18e-06	2.74e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CASP3—epilepsy syndrome	5.13e-06	2.71e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	4.99e-06	2.64e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—JUN—epilepsy syndrome	4.98e-06	2.63e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	4.87e-06	2.57e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MMP9—epilepsy syndrome	4.85e-06	2.56e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	4.84e-06	2.55e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.81e-06	2.54e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.8e-06	2.54e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CASP3—epilepsy syndrome	4.77e-06	2.52e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—JUN—epilepsy syndrome	4.63e-06	2.45e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MMP9—epilepsy syndrome	4.51e-06	2.38e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SRC—epilepsy syndrome	4.47e-06	2.36e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.38e-06	2.31e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—AKT1—epilepsy syndrome	4.37e-06	2.31e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	4.36e-06	2.31e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—VEGFA—epilepsy syndrome	4.35e-06	2.3e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—AKT1—epilepsy syndrome	4.31e-06	2.28e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—AKT1—epilepsy syndrome	4.27e-06	2.26e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SRC—epilepsy syndrome	4.16e-06	2.2e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	4.15e-06	2.19e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—BCHE—epilepsy syndrome	4.14e-06	2.19e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—VEGFA—epilepsy syndrome	4.05e-06	2.14e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—AKT1—epilepsy syndrome	3.97e-06	2.1e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	3.95e-06	2.08e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—AKT1—epilepsy syndrome	3.93e-06	2.08e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	3.9e-06	2.06e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—TH—epilepsy syndrome	3.89e-06	2.05e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.83e-06	2.02e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—AKT1—epilepsy syndrome	3.81e-06	2.02e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—AKT1—epilepsy syndrome	3.75e-06	1.98e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—AKT1—epilepsy syndrome	3.57e-06	1.89e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—AKT1—epilepsy syndrome	3.47e-06	1.84e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—AKT1—epilepsy syndrome	3.34e-06	1.77e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—AKT1—epilepsy syndrome	3.3e-06	1.75e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	3.25e-06	1.72e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CAT—epilepsy syndrome	3.2e-06	1.69e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	3.12e-06	1.65e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.9e-06	1.53e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—AKT1—epilepsy syndrome	2.78e-06	1.47e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—AKT1—epilepsy syndrome	2.58e-06	1.36e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.54e-06	1.34e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.49e-06	1.31e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.14e-06	1.13e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.95e-06	1.03e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.71e-06	9.01e-06	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AKT1—epilepsy syndrome	8.57e-07	4.53e-06	CbGpPWpGaD
